Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Fish and Richardson
Citi
Baxter
US Department of Justice
Harvard Business School

Generated: August 21, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for GKT137831

  Try a free trial


See Plans and Pricing

« Back to Dashboard

US Patents for GKT137831

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
GKT137831   Try a Free Trial Pyrazolo pyridine derivatives as NADPH oxidase inhibitors GENKYOTEX SA (Plan-les-Ouates, CH)   Try a Free Trial
GKT137831   Try a Free Trial Methods of preserving and protecting pancreatic beta cells and treating or preventing diabetes by inhibiting NOX-1 Eastern Virginia Medical School (Norfolk, VA)   Try a Free Trial
GKT137831   Try a Free Trial Orvepitant for chronic cough therapy NeRRe Therapeutics Limited (Herts, GB)   Try a Free Trial
GKT137831   Try a Free Trial Method of treatment of chronic cough administering orvepitant in combination with other therapeutic agents NeRRe Therapeutics Limited (Herts, GB)   Try a Free Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Subscribe to access the full database, or try a Free Trial

International Patents for GKT137831

Drugname Country Document Number Estimated Expiration Related US Patent
GKT137831 Australia 2009298008 2028-09-23   Try a Free Trial
GKT137831 Brazil PI0919330 2028-09-23   Try a Free Trial
GKT137831 Canada 2737550 2028-09-23   Try a Free Trial
GKT137831 China 102159573 2028-09-23   Try a Free Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
QuintilesIMS
US Department of Justice
UBS
Accenture
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.